Skip to main content

Bausch Health Companies Inc(BHC-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume
Day Low7.50
Day High7.68
Open:7.59
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

Download Premium PDFRefinitiv. Trademark. Data is Just the Beginning.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Download Premium PDFStockCalc

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Download Premium PDFValueEngine

Press & news

Latest News

More Stories
Bausch Health Announces Changes to its Board of Directors
ACCESSWIRE - Wed Mar 1, 2:00AM CST
ACCESSWIRE
Wed Mar 1, 2:00AM CST
LAVAL, QC / ACCESSWIRE / March 1, 2023 / Bausch Health Companies Inc. (TSX:BHC)(NYSE:BHC) today announced that Richard De Schutter and Dr. Argeris Karabelas are retiring from the Company's Board of Directors, effective as of the upcoming 2023...
Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results
ACCESSWIRE - Thu Feb 23, 1:00AM CST
ACCESSWIRE
Thu Feb 23, 1:00AM CST
LAVAL, QC / ACCESSWIRE / February 23, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced its fourth-quarter and full-year 2022 financial results.
Salix Announces 2023 Gastrointestinal Health Scholars Program
ACCESSWIRE - Mon Feb 13, 2:00AM CST
ACCESSWIRE
Mon Feb 13, 2:00AM CST
Salix to Provide Scholarships to 10 Students Living with GI Diseases

Latest Articles

The Globe’s stars and dogs for 2022: Tasty fast-food returns and a rough year for Disney princesses and crypto
Bausch Health reports US$69-million first-quarter loss, revenue down from year ago
Laval-based pharmaceutical company Bausch + Lomb plans US$788-million IPO
Shopify’s decline contributes to the quirky ‘Canadian curse’ of the TSX
Bausch Health preparing for spinoff of eye-care unit this fall
Bausch Health selling stake in Egypt’s Amoun for $740-million
Bausch Health names Sam Eldessouky as next CFO
Bausch Health to add two directors from Icahn Group to board
Bausch Health shareholder pushes for completion of eye-care spinoff by end of 2021
Thursday’s analyst upgrades and downgrades
Bausch Health to spin-off eye care business, shares soar 28%
Wednesday’s analyst upgrades and downgrades

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2023 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.